AlzeCure Pharma AB (publ) (STO:ALZCUR)

Sweden flag Sweden · Delayed Price · Currency is SEK
1.865
-0.030 (-1.58%)
Mar 9, 2026, 5:29 PM CET
-14.45%
Market Cap 214.32M
Revenue (ttm) n/a
Net Income (ttm) -47.65M
Shares Out 114.91M
EPS (ttm) -0.47
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 68,571
Average Volume 44,218
Open 1.875
Previous Close 1.895
Day's Range 1.780 - 1.875
52-Week Range 1.500 - 4.950
Beta -0.09
RSI 43.02
Earnings Date Feb 26, 2026

About AlzeCure Pharma AB

AlzeCure Pharma AB (publ) operates as a pharmaceutical company that develops drug therapies for the treatment of severe diseases and conditions that affect the central nervous system. The company is involved in the development of drug candidates based on the NeuroRestore, Alzstatin, and Painless research platforms. Its products pipeline includes ACD856 for the treatment of Alzheimer’s disease, sleep disorders, depression, traumatic brain injuries, and Parkinson’s disease, which is in phase I clinical trial; ACD857, ACD679, and ACD680 that are i... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2012
Employees 11
Stock Exchange Nasdaq Stockholm
Ticker Symbol ALZCUR
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.